Trial Profile
Evaluation of tacrolimus (Prograf) intraportal infusion during the implantation and the protective effect on ischemia reperfusion injury in orthotopic liver transplant recipients single center study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection; Reperfusion injury
- Focus Therapeutic Use
- 07 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2008 New trial record.